@sofiebio

We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics).

 Dulles, VA
sofie.com
Joined April 2010
  • Tweets901
  • Following784
  • Followers555
146Media
In January, we launched our iPREDICT clinical trial globally in the US, Australia, and Europe. ​ We are proud to announce the first patient dosed in Australia.​ ​Read more here: imaginab.com/news-events/new… #Australiabiotech #immunotherapy #immunooncology #clinicaltrials
1
4
Very excited to test the ability of a novel molecular imaging agent targeting fibroblast activated protein (FAP) to pick up pancreatic cancer!” @sofie @elcinzan @nyulangone ⁦@Perlmutter_CC⁩ #imagingpancreaticcancer prnewswire.com/news-releases…

First Patient Imaged in SOFIE's FAPI Phase II trial

/PRNewswire/ -- SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged the first patient with...

prnewswire.com
2
5
Eisai Co. and partner Biogen Inc. said their Alzheimer’s drug lecanemab slowed the disease, becoming the first medicine to clearly blunt the progression of the most common type of dementia in a final-phase trial $BIIB
1
14
6
53
Read the FDA's reasoning and remember that @NCCN and @SNM_MI guidelines support the use of other validated and FDA-approved imaging probes for PLUVICTO treatment stratification. ow.ly/i7uQ50JSg9o #PrecisionMedicine #NucMed #ProstateCancer
2
6
9
This is your last week to submit an abstract for WMIC! Submit by July 15th, 2022. Present your science in Miami and don't forget to book your hotel: wmis.org/wmic1/
9
9
Current Issue: Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging dlvr.it/STN0Dh
9
18
Thanks @SNM_MI for the 2022 Alavi-Mandell award for this @JournalofNucMed publication. Recognition goes to all authors. #PSMA #ProstateCancer #nuclearmedicine snmmi.org/AboutSNMMI/Content…
This quoted post is unavailable.
Try viewing anyway · View on X
4
9
1
39
Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer dlvr.it/SRC7Rq

Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate...

Background Data regarding 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid (18F-DCFPyL) PET in primary staging of prostate cancer (PCa) are limited....

pubmed.ncbi.nlm.nih.gov
1
O. Sartor discusses the role of PSMA PET/CT for selecting patients for radioligand therapy. Thoughts? Please comment! ow.ly/aIhI50Jk05n #MedicalImaging #PETCT #ProstateCancer @sartor_oliver

Invited Perspective, Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and...

jnm.snmjournals.org
5
17
Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and Beyond @asco Education Book #ASCO22 ascopubs.org/doi/full/10.120… @DrAGafita @LouiseKostos @CalaisJeremie @pros_tic
1
21
66
We invite all WMIC 2022 attendees to fill out our pre-conference survey! ✨We want your input and feedback on WIMIN events you'd like to see at the upcoming WMIC conference. Fill out a survey & have a chance to win a $25 Amazon gift cards✨ surveymonkey.ca/r/YCRVYJT @WMISWMIC
4
2
4
Impressive and inspiring talk by Jason Lewis @LewisLabMSKCC at the @CRUK_BI today. Jason gave us an excellent vision of the future for #PET imaging and #theranostics. Phenomenal data.
3
4
49
Also great to see 177Lu-PSMA-617 added to the NCCN guidelines. As expected post-chemo and post-ARTT. Nice speedy updates by the NCCN panel. #PSMARLT bit.ly/3LkJV2v
3
14
51
Glad to see that the NCCN agrees that either 18F-DCFPyL or 68Ga-PSMA-11 should be used for selection of patients for 177Lu-PSMA-617 radioligand therapy. Hopefully we can put this issue to rest as soon as possible! #PSMAPET - bit.ly/3LkJV2v
4
19
1
70
Look forward to seeing you all @WMISWMIC #molecular imaging #science #innovation @UCDavisResearch @LewisLabMSKCC @UCDavisCMGI @juliesut8
WMIS WMIC@WMISWMIC26 Apr 2022
REMINDER: WMIC 2022 abstract deadline is next Wednesday, May 4th, 2022. Submit your abstract: ow.ly/bxRb50ISZP6 We can't wait to see you in Miami!
2
11
bloomberg.com/news/articles/…
4
12
2
140
Huge thank-you to @PCFA and @MovemberAUS .. they funded the #ProPSMA clinical trial back in 2015 when few had heard of this new technology PSMA PET/CT. Their support and vision was critical to enable this 10-site Australian study producing highest level of evidence.
PCFA@PCFA6 Apr 2022
GREAT NEWS! The Federal Government has announced PSMA PET/CT will be listed from July 1 for men with intermediate to high-risk and recurrent #prostatecancer. Read the full story at bit.ly/35M3LVQ @PeterMacCC @ProfJeffDunn @declangmurphy @DrMHofman @ANZUPtrials
10
36
FAPI-PET opens a new window for understanding of immune-mediated inflammatory diseases. ow.ly/3HFC50IEQsU #MedicalImaging #PETimaging #Inflammation
24
1
45
TSPO PET for inflammation imaging only? Our @PNASNews paper shows how TSPO PET can be used to track immune cells at the organ level and better understand infection pathophysiology. @NIHRadiology @IRPatNIH @WMIS_IOI pnas.org/doi/epdf/10.1073/pn…
1
4
1
25
Current Issue: Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer dlvr.it/SMwzCP
3
9
Load more